TRT Blood Tests UK: What to Monitor Before, During & After Testosterone Replacement Therapy

Why blood tests matter more on TRT than almost any other medication

Testosterone replacement therapy is one of the fastest-growing prescriptions in UK men's health. Private TRT clinics have expanded rapidly since 2020, and NHS prescriptions for testosterone products have risen year on year. Whether prescribed by your GP, an NHS endocrinologist, or a private clinic, TRT requires regular blood monitoring — more frequently and more comprehensively than most men realise.

Unlike medications that target a single pathway, testosterone affects virtually every organ system. It increases red blood cell production (raising haematocrit and stroke risk), alters cholesterol metabolism (shifting your lipid profile), converts to oestradiol via aromatisation (affecting mood, water retention, and breast tissue), and stimulates prostate tissue growth (making PSA monitoring essential). A single marker — total testosterone — tells you almost nothing about whether your TRT is safe and effective.

The British Society for Sexual Medicine (BSSM) 2022 guidelines set the standard for TRT monitoring in the UK. This guide walks through every marker the BSSM recommends, explains what each one tells you, and highlights the gaps that NHS monitoring routinely leaves — gaps that a comprehensive private panel fills.

Before you start

The baseline blood tests you need before starting TRT

No responsible prescriber should start TRT without a comprehensive baseline. The BSSM requires at least two early-morning testosterone readings (before 11am, fasted) on separate days showing levels below the diagnostic threshold, plus bloods to rule out secondary causes and establish safety parameters. Here is the full baseline panel:

Why this list is longer than what most GPs order: NHS baseline for TRT typically covers total testosterone, LH, FBC, PSA, and liver function. It usually omits free testosterone, SHBG, oestradiol, prolactin, thyroid function, vitamin D, and a full lipid panel. These omissions matter — a borderline total testosterone with a high SHBG means your free testosterone may be genuinely low even if the total looks acceptable. An unchecked oestradiol means your prescriber has no baseline if you develop gynaecomastia. A missed hypothyroidism diagnosis means you may be starting TRT for symptoms that would resolve with levothyroxine.

During treatment

The monitoring schedule: when and what to test on TRT

The BSSM 2022 guidelines recommend the following monitoring schedule after starting or adjusting TRT. Most private clinics follow a similar pattern. NHS endocrinology departments may use wider intervals.

Timing matters: If you use testosterone injections (Sustanon 250 or Nebido/testosterone undecanoate), your blood should be drawn at trough — the morning before your next injection, when testosterone is at its lowest. This prevents a falsely reassuring high reading taken 24–48 hours after injection. If you use daily testosterone gel (Testogel, Tostran), test 2–4 hours after application for a steady-state reading.

The markers that matter most

Five TRT markers your prescriber watches most closely

NHS vs private monitoring

What the NHS TRT monitoring panel misses

If your GP prescribed TRT, they will typically order monitoring bloods through the NHS. This is a good starting point — but it has predictable gaps. If your TRT was prescribed by a private clinic, your NHS GP may not offer monitoring at all, making a private panel your only option.

The NHS covers 5 of the 15 markers a comprehensive TRT monitoring panel should include. The omissions are not negligence — NHS guidelines prioritise cost-effectiveness across a population, not individual optimisation. But for a man spending £50–£200 per month on TRT, investing £89–£149 in a comprehensive blood panel every 3–6 months is not a luxury. It is the minimum due diligence.

TRT delivery methods

How delivery method affects your blood test results

Different TRT formulations produce different pharmacokinetic profiles. This matters because it changes when you should test and what you should expect.

Result patterns

Five common TRT blood test patterns and what they mean

Red flags

Results that require urgent action

Most TRT monitoring results require discussion at your next appointment. A small number require immediate action. Contact your prescriber (or attend A&E if they are unavailable) for any of the following:

These thresholds are not arbitrary — they are drawn directly from the BSSM 2022 guidelines and the EAU 2023 guidelines on male hypogonadism.

Stopping treatment

Blood tests after stopping TRT

If you decide to stop TRT — or your prescriber recommends cessation — your body needs time to restart endogenous testosterone production. The hypothalamic-pituitary-gonadal (HPG) axis, suppressed by exogenous testosterone, must recover. This can take weeks to months depending on the duration and dose of TRT.

Blood tests at 4 weeks, 8 weeks, and 12 weeks post-cessation help your prescriber assess whether your HPG axis is recovering. Key markers to track:

• ●Total testosterone + LH + FSH — LH and FSH should rise as the pituitary resumes signalling. If LH remains suppressed at 12 weeks, recovery may be delayed and further investigation is needed.
• ●Haematocrit — should normalise within 3–6 months as erythropoietin drive decreases.
• ●Oestradiol — may transiently rise or fall during recovery. Symptom monitoring matters more than absolute values during this phase.
• ●Mood and energy — subjective, but clinically relevant. If symptoms of testosterone deficiency return and bloods confirm low T + rising LH/FSH, your prescriber may discuss resuming TRT or investigating underlying causes.

Men who have been on TRT for years should expect a longer recovery period. Some men with primary hypogonadism (testicular cause) may not recover endogenous production — this is expected and is the reason they were started on TRT in the first place.

How we compare

GP TRT monitoring vs a comprehensive Helvy panel

For most men on TRT, the ideal monitoring strategy combines both: NHS monitoring for the core safety markers (free on the NHS if your GP prescribes), supplemented by a comprehensive private panel 1–2 times per year to catch the markers the NHS omits. The combined cost is modest relative to the monthly cost of TRT itself.

Which panels to choose

The Helvy panels that cover TRT monitoring

No single Helvy panel covers every TRT marker. Here is how to build comprehensive monitoring from our existing panels:

For comprehensive TRT monitoring: Hormone Male + Essential covers the BSSM-recommended markers. Adding Heart gives you ApoB and Lp(a) for detailed cardiovascular risk assessment. Many men on TRT choose to run Hormone Male + Essential every 3 months during the first year, then annually with Heart added.

Evidence base

Key references

• ●BSSM Guidelines on Adult Testosterone Deficiency (2022) — the definitive UK clinical guideline for testosterone deficiency diagnosis and TRT monitoring
• ●TRAVERSE Trial (NEJM, 2023) — landmark RCT showing no increased cardiovascular events in men with hypogonadism receiving TRT vs placebo
• ●EAU Guidelines on Male Hypogonadism (2023) — European urology guidelines including monitoring recommendations and contraindications
• ●T4DM Trial (Lancet Diabetes & Endocrinology, 2021) — 41% reduction in type 2 diabetes incidence in men with low T receiving TRT + lifestyle intervention
• ●NICE CG181: Cardiovascular disease risk assessment and management — lipid monitoring context for TRT users
• ●NHS: Low testosterone (male hypogonadism) — general patient information on testosterone deficiency and NHS treatment pathways

Common questions

TRT blood test FAQs